These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 880264)

  • 21. Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene.
    May SW; Mueller PW; Padgette SR; Herman HH; Phillips RS
    Biochem Biophys Res Commun; 1983 Jan; 110(1):161-8. PubMed ID: 6860408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of adrenal dopamine-beta-hydroxylase by 6-hydroxy dopamine.
    Aunis D; Miras-Portugal MT; Mandel P
    Biochem Pharmacol; 1973 Oct; 22(20):2581-9. PubMed ID: 4763594
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of dopamine beta-hydroxylase by 4-hydroxypyrazole: ethanol-pyrazole effects on serum dopamine beta-hydroxylase in vivo.
    Harralson JD; Wolfe BI; Brown FC
    J Pharmacol Exp Ther; 1978 Jul; 206(1):69-74. PubMed ID: 660559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 25. The inhibitory effect of serum from diethyldithiocarbamate treated rats on bovine adrenal dopamine-beta-hydroxylase activity.
    Jarvis JA; Magos L; Jacobs R
    J Appl Toxicol; 1981 Feb; 1(1):26-9. PubMed ID: 6309944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism and kinetics of the inhibition of dopamine-beta-hydroxylase by 2-mercaptoethylguanidine.
    Diliberto EJ; DiStefano V; Smith JC
    Biochem Pharmacol; 1973 Dec; 22(23):2961-72. PubMed ID: 4761561
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole.
    Ferreira AC; de Carvalho Cardoso L; Rosenthal D; de Carvalho DP
    Eur J Biochem; 2003 Jun; 270(11):2363-8. PubMed ID: 12755690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies on irreversible inhibition of dopamine-beta-hydroxylase by cysteine.
    Izumi H; Hayakari M; Ozawa H
    Tohoku J Exp Med; 1976 Apr; 118(4):373-80. PubMed ID: 936210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithyroid drugs interact with renal medullary prostaglandin H synthase.
    Zelman SJ; Rapp NS; Zenser TV; Mattammal MB; Davis BB
    J Lab Clin Med; 1984 Aug; 104(2):185-92. PubMed ID: 6205111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings.
    Davidson B; Soodak M; Neary JT; Strout HV; Kieffer JD; Mover H; Maloof F
    Endocrinology; 1978 Sep; 103(3):871-82. PubMed ID: 744122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGE2, phenylephrine and dopamine-beta-hydroxylase release from rat adrenal in vitro.
    Boonyaviroj P; Seiden A; Gutman Y
    Biochem Pharmacol; 1977 Feb; 26(4):351-2. PubMed ID: 849327
    [No Abstract]   [Full Text] [Related]  

  • 32. Propylthiouracil and thiamazole do not alter in vitro neutrophil oxidative burst.
    Russo-Carbolante EM; Azzolini AE; Polizello AC; de Assis-Pandochi AI; Lucisano-Valim YM
    Metabolism; 2005 Mar; 54(3):300-5. PubMed ID: 15736106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of dopamine-beta-hydroxylase by hydralazine.
    Liu TZ; Shen JT; Loken HF
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):294-7. PubMed ID: 4812865
    [No Abstract]   [Full Text] [Related]  

  • 34. Intracellular distribution of endogenous inhibitors of dopamine -hydroxylase in bovine adrenal medulla.
    Kuzuya H; Negatsu T
    Biochem Pharmacol; 1972 Mar; 21(5):740-2. PubMed ID: 5063171
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of dopamine -hydroxylase by 5-phenoxymethyl-2-oxazolidinethiones.
    Johnson GA; Kim EG; Boukma SJ; Lednicer D; Youngdale GA
    J Med Chem; 1972 Mar; 15(3):327-9. PubMed ID: 5059221
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-thyroid thioureylenes in the treatment of psoriasis.
    Elias AN
    Med Hypotheses; 2004; 62(3):431-7. PubMed ID: 14975517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of two copper-containing enzymes, tyrosinase and dopamine beta-hydroxylase, by L-mimosine.
    Hashiguchi H; Takahashi H
    Mol Pharmacol; 1977 Mar; 13(2):362-7. PubMed ID: 404519
    [No Abstract]   [Full Text] [Related]  

  • 38. Methimazole and propylthiouracil increase cellular thyroid peroxidase activity and thyroid peroxidase mRNA in cultured porcine thyroid follicles.
    Sugawara M; Sugawara Y; Wen K
    Thyroid; 1999 May; 9(5):513-8. PubMed ID: 10365684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of propylthiouracil, methimazole and thyroidectomy on liver ferritin.
    Deshpande UR; Nadkarni GD
    Exp Clin Endocrinol; 1983 Aug; 82(2):242-5. PubMed ID: 6685048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An increase of liver uptake of thyroxine, an initial step of an increased fecal loss of thyroxine in response to propylthiouracil in rats.
    Yamada T; Koizumi Y; Kojima A
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):21-9. PubMed ID: 1015911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.